Results 21 to 30 of about 40,079 (267)

Effects of age on hypoxic tolerance in women

open access: yesCurrent Issues in Sport Science, 2023
Introduction The prevalence of acute mountain sickness (AMS) is increasing with altitude (i.e., 10-25% at 2,500 m and 50-85% at ~ 5,000 m; Bärtsch & Swenson, 2013). While there is no error-free test to predict its occurrence, several risk factors and
Tom Citherlet   +3 more
doaj   +1 more source

Variants of the low oxygen sensors EGLN1 and HIF-1AN associated with acute mountain sickness. [PDF]

open access: yes, 2014
Two low oxygen sensors, Egl nine homolog 1 (EGLN1) and hypoxia-inducible factor 1-α inhibitor (HIF-1AN), play pivotal roles in the regulation of HIF-1α, and high altitude adaption may be involved in the pathology of acute mountain sickness (AMS).
Huang, Lan   +5 more
core   +3 more sources

Smartphone-Enabled Heart Rate Variability and Acute Mountain Sickness [PDF]

open access: yes, 2017
INTRODUCTION: The autonomic system and sympathetic activation appears integral in the pathogenesis of acute mountain sickness (AMS) at high altitude (HA), yet a link between heart rate variability (HRV) and AMS has not been convincingly shown.
Bakker-Dyos, J   +5 more
core   +2 more sources

High-altitude illness: Management approach

open access: yesTurkish Journal of Emergency Medicine, 2019
In high altitudes, usually above 2500 m, travelers are faced with decreased partial pressure of oxygen along with decreased barometric pressure. High-altitude illness, a syndrome of acute mountain sickness, high-altitude cerebral edema and high-altitude ...
Gökhan Aksel   +2 more
doaj   +1 more source

Prevention and treatment of high altitude cerebral edema (HACE)

open access: yesJournal of Education, Health and Sport, 2020
High altitude cerebral edema (HACE) is often a severe and potentially fatal manifestation of acute mountain sickness (AMS). It usually develops within the first 2 in individuals rapidly ascending at altitudes above 4000 m.
Karol Mazur   +4 more
doaj   +1 more source

Neutrophil gelatinase-associated lipocalin: its response to hypoxia and association with acute mountain sickness. [PDF]

open access: yes, 2013
Acute Mountain Sickness (AMS) is a common clinical challenge at high altitude (HA). A point-of-care biochemical marker for AMS could have widespread utility.
Begley, J   +11 more
core   +2 more sources

Journal of The Nepal Medical Association- Editorial

open access: yesJournal of Nepal Medical Association, 2003
Man And The Mountains HIgh Altitude Pulmonary Oedema And Acute Mountain ...
JNMA Editorial
doaj   +1 more source

Hypoxia-related mechanisms inducing acute mountain sickness and migraine

open access: yesFrontiers in Physiology, 2022
Experimental models of human diseases are vital for pathophysiological and therapeutic research. To investigate the initiation, maintenance, pathophysiology and even termination of a migraine/headache attack these models are urgently needed. Results from
Florian Frank   +3 more
doaj   +1 more source

Does This Patient Have Acute Mountain Sickness?: The Rational Clinical Examination Systematic Review. [PDF]

open access: yes, 2017
Acute mountain sickness (AMS) affects more than 25% of individuals ascending to 3500 m (11 500 ft) and more than 50% of those above 6000 m (19 700 ft).
Collet, T.H.   +6 more
core   +2 more sources

Response to letter to the editor regarding “Acute mountain sickness among tourists visiting the high-altitude city of Lhasa, Tibet, China at 3658 m above sea level: a cross-sectional study”

open access: yesArchives of Public Health, 2017
We kindly thank the journal for the opportunity to respond to the recent comments made regarding our manuscript entitled “Acute mountain sickness among tourists visiting the high-altitude city of Lhasa, Tibet, China at 3658 m above sea level: A cross ...
Gonggalanzi, Per Nafstad
doaj   +1 more source

Home - About - Disclaimer - Privacy